LMI, formerly a not-for-profit consultancy led by Wash100 Award winner and CEO Doug Wagoner, has consistently shown its dedication to advancing healthcare processes. Through strategic partnerships and cutting-edge solutions, they are making a positive impact on both veterans and Medicare beneficiaries.
For instance, in July, LMI secured a $55 million, five-year contract with the Centers for Medicare and Medicaid Services to support the Medicare Shared Savings Program. Their efforts involve providing policy deployment, compliance solutions, and operations with advanced data analytics to drive performance optimization. In October, they were awarded a $19.6 million contract by the Department of Veterans Affairs to enhance suicide prevention strategies. By leveraging analytics, they are setting national research priorities and improving clinical decision-making frameworks for at-risk veterans. Zaki Saleh, LMI's senior vice president for the health and civilian market, continues to spearhead healthcare transformations and was recognized as the chair of the Healthcare Group in Executive Mosaic's prestigious 4×24 Leadership Program.
LMI VP of Business Transformation and Total Experience Rick Shah will introduce the closing keynote speaker Lee Ann Crochunis, deputy director of the Office of Information Technology at CMS, at the 2024 Healthcare Summit. The company's Bioinformatics Principal Dr. Alexander Holston will also lead a panel discussion, "Innovation at the Pace of Need: From Idea to MVP" at the event.
Through robust IT services and modernization initiatives, the multibillion-dollar powerhouse SAIC is empowering government agencies like the VA to adopt secure, flexible, and future-ready technologies. Toni Townes-Whitley leads SAIC.
SAIC secured a spot on the Transformation Twenty-One Total Technology Next Generation Two (T4NG2) contract in January, valued at $60.7 billion. Their work supports the VA in delivering IT infrastructure, system engineering, application development, and cybersecurity services. Their role in the National Institutes of Health Information Technology Acquisition and Assessment Center, Chief Information Officer – Solutions and Partners 3 vehicle positions them as a leader in providing comprehensive IT services for healthcare innovation, covering everything from legacy system maintenance to emerging digital solutions.
SAIC Health Market Leader Heath Starr will lead a panel discussion, "The Convergence of Healthcare, Technology and Citizen Experience" at the 2024 Healthcare Summit. Karen Brazell, the company's VP for the VA account, will introduce keynote speaker Jennifer Wendel, chief information officer at HHS.
With a focus on blending technology and strategy, Fairfax, Virginia-based consultancy ECS is at the forefront of healthcare system modernization and support. John Heneghan, another Wash100 Award winner and president, leads the way.
ECS is delivering essential technical services under NIH's $500 million Advanced Research Projects Agency for Health initiative announced in December 2023. This contract highlights their capabilities in providing strategic talent support to accelerate ambitious healthcare research. They are also one of 17 contractors awarded a $650 million health technology contract to enhance the VA's healthcare systems.
At the 2024 Healthcare Summit, ECS Director of Data and Mission Partner Sharing Dr. Kimberly Eldenberg will oversee the panel discussion "Humanitarian Assistance and Disaster Response (HADR): Increasing Survivability Through ML/AI." Meanwhile, VP of Civilian Health Accounts Tom Lapato will provide an intro for morning keynote speaker Jeffrey Neill, the associate executive director of the Technology Acquisition Center at the VA.
The newest organization on the list, Tria Federal, is the result of a three-way merger in Q1 2023 and is an exciting new voice in healthcare consulting. Their expertise in IT integration and management is helping healthcare entities improve operational outcomes across defense and civilian sectors.
Tria Federal is an integral player in the Defense Health Agency's Omnibus IV contract, collaborating with military health systems to maximize efficiency and readiness. Their work under notable frameworks like T4NG and CIO-SP3 underscores their focus on delivering IT excellence with a core emphasis on digital transformation and healthcare accessibility.
Tria Chief Technology Officer John Cho will speak on a panel discussion entitled "Applied AI – Elevate Ideas to Reality" at the Potomac Officers Club's 2024 Healthcare Summit.
Multinational tech company Digital Science is consistently advancing research capabilities in the healthcare sector through its cutting-edge digital platforms, such as Dimensions.
Digital Science's $6 million subscription awarded by the NIH allows for groundbreaking capabilities in data discovery and predictive analysis, equipping healthcare professionals with better decision-making tools. At the 2024 Healthcare Summit, Emily Algha, DS Senior Director of Research Analytics & Support, will moderate a panel discussion about AI's role in research to real world impact. The company's director of U.S. federal business, Meghan Becker, will introduce the opening keynote speaker of the event, Steven Posnack, principal deputy assistant secretary for technology policy at the Office of the National Coordinator for Health Information Technology within HHS.
AWS' advanced cloud technologies provide healthcare organizations with a reliable and secure infrastructure to drive innovation and efficiency.
With a focus on scalability, security, and agility, AWS delivers tools to improve patient outcomes, enhance collaboration, and streamline data management. Dr. Chris Caggiano, AWS Principal Medical Officer, will be a part of the "Catalyzing Clinical Translation: AI's Role in Research to Real World Impact" panel at the 2024 Healthcare Summit.
Red Hat remains a trusted leader in supporting government contractors by delivering adaptable and secure IT environments.
Through its offerings in open-source technologies, Red Hat drives digital transformation for the healthcare sector. Their innovative solutions help organizations achieve high levels of infrastructure flexibility and cost-effectiveness. At the 2024 Healthcare Summit, look out for the "Applied AI – Elevate Ideas to Reality Panel"; Red Hat Chief Architect of Health and Life Sciences Ben Cushing will moderate.
As a pioneer in AI-driven solutions for proposal writing, AutogenAI is transforming how healthcare contractors approach tenders and bids.
AutogenAI empowers bid-writing teams with an innovative tool designed to streamline workflows, enhance efficiency, and improve the quality of proposals. This solution enables contractors to win more bids while saving valuable time and resources.
These top healthcare government contractors are playing a critical role in shaping the future of healthcare. From leveraging advanced AI to modernizing IT infrastructures and delivering secure cloud solutions, their work is essential in addressing complex challenges faced by government agencies. Dive into the exclusive chance to connect with these game-changing teams all in one place at the Potomac Officers Club's 2024 Healthcare Summit on Dec. 11!
The new clinic will bring a wide range of essential healthcare services to women. Pap testing, a crucial preventive measure for cervical cancer, will be readily available. Mammogram referrals will ensure early detection of breast cancer, saving countless lives. Pregnancy testing will offer timely information to expectant mothers. Additionally, contraception services will empower women to make informed decisions about their reproductive health.
By providing these comprehensive services under one roof, the clinic aims to address the diverse healthcare needs of women. It will serve as a one-stop destination for all their health-related concerns.
The clinic will play a vital role in supporting pregnant women. It will offer established resources and excellent care during pregnancy, ensuring the well-being of both the mother and the baby. Once the pregnancy progresses, seamless handoffs into prenatal care will ensure continuous and quality healthcare. This holistic approach aims to create a healthy community with healthy moms and babies.
With the provision of STD testing, drug screening, mental health programs, and Medicaid navigation, the clinic is truly comprehensive. It addresses not only physical health but also the mental and social aspects of a woman's well-being.
The City of Amarillo is excited to announce that the new clinic is set to open its doors in mid-2025. This long-awaited facility will bring much-needed healthcare services to the women of Amarillo and the surrounding areas. It represents a significant investment in the health and well-being of the community.
As the opening date approaches, anticipation is building among women and healthcare providers alike. The new clinic is expected to make a positive impact on the lives of countless women and families in the region.
Biological measures are driving the growth of precision psychiatry. Researchers have been studying various biomarkers for decades, including memory, genes, cognitive performance, speech, hormones, and gut microbes. While some associations have been found between these biomarkers and mental health, few have been used to categorize patients in clinical trials. ERPs, on the other hand, have shown high test-retest reliability and interpretability across different mental health conditions. They can be used to measure brain responses to rewards, emotional content, and decision-making, and have been linked to specific subtypes of depression and the prediction of treatment outcomes.
For example, a 2023 study of adolescents with depression found that an ERP associated with the response to emotional stimuli predicted a response to cognitive behavioral therapy. This suggests that ERPs could serve as neural biomarkers for predicting outcomes in adolescent depression. Another study published in the Annual Review of Clinical Psychology in 2019 concluded that ERPs can be used clinically to identify psychopathology and chart the potential development of conditions starting from childhood. The error-related negativity ERP was found to be instrumental in understanding the development of anxiety disorders and treatment opportunities.
ERPs have been studied since the 1960s primarily in psychological and academic research. They have been used to study a wide range of cognitive domains, including memory, attention, vision, and emotion. In recent years, ERP biomarkers have helped uncover insights into mental health, especially in challenging conditions like schizophrenia. Promising ERP biomarkers of depression have focused on brain responses to rewards, emotional content, and decision-making. These ERPs have not only been linked to depression but also accurately predicted individuals' risk for depression and its development over time.
For instance, a 2019 meta-analysis found that ERPs can be used clinically to help identify psychopathology and track the potential development of conditions. Later research showed that ERPs associated with receiving rewards were closely tied to depression and could predict remission. Combining emotion- and reward-related ERPs could help differentiate subtypes of depression and improve treatment precision.
ERPs measured through EEG have been shown to be instrumental in scientific research. There are significant opportunities for pharmaceutical companies to incorporate ERPs in clinical trials to develop more personalized treatments. Compared to functional magnetic resonance imaging (fMRI), ERP data is easier and less expensive to capture. EEG studies are relatively simple to administer, and electrodes do not require messy conductive gel. ERP measures of brain function are also more reliable than fMRI-based measures, which can help pharmaceutical companies develop novel therapies in less time and with fewer resources.
Investigators can use ERPs to measure brain function at every phase of a clinical trial. At participant recruitment, a quick ERP assessment can identify appropriate participants who would benefit most from a drug. This helps ensure homogeneity among different cohorts and supports more streamlined clinical trials. In addition, ERP data can be used to monitor treatment responses and predict outcomes.
With advancements in data science techniques like generative AI, ERPs are becoming more accessible and affordable. Technological progress has simplified EEG studies and ERP data analysis, making these biomarkers more practical for clinicians and patients. Given the growing evidence in peer-reviewed journals, we can expect ERPs to become more incorporated in mental health clinical trials in 2025. ERPs are poised to move from academic labs to real-world importance and become a standard method of assessing brain function in precision psychiatry.